3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
7
Phase 1/2
3
Phase NA
1
Phase 3
1
Phase 2/3
1
Phase 1
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Lymphoma
10
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Multiple Myeloma
8
Leukemia, Myeloid, Acute
8
Hodgkin Disease
8
Recurrence
6
Lymphoma, Non-Hodgkin
6
Lymphoma, Large B-Cell, Diffuse
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Leukemia
6
Burkitt Lymphoma
6
Myelodysplastic Syndromes
5
Lymphoma, T-Cell, Cutaneous
5
Lymphoma, Mantle-Cell
5
Lymphoma, Large-Cell, Immunoblastic
5
Lymphoma, Follicular
5
Lymphoma, B-Cell, Marginal Zone
5
Neuroblastoma
4
Lymphoma, Large-Cell, Anaplastic
4
Leukemia, Myeloid, Chronic-Phase
4
Leukemia, Myeloid, Accelerated Phase
4
Dendritic Cell Sarcoma, Interdigitating
4
Congenital Abnormalities
4
Waldenstrom Macroglobulinemia
3
Sezary Syndrome
3
Retinoblastoma
3
Primary Myelofibrosis
3
Myeloproliferative Disorders
3
Mycosis Fungoides
3
Lymphoma, Extranodal NK-T-Cell
3
Interventions
Cyclosporine
4
fludarabine phosphate
3
Mycophenolic Acid
3
Cyclophosphamide
3
Whole-Body Irradiation
2
Peripheral Blood Stem Cell Transplantation
2
Cord Blood Stem Cell Transplantation
2
pegaspargase
1
Vincristine
1
Thioguanine
1
Therapeutics
1
Specimen Handling
1
Radiotherapy
1
Prednisone
1
Prednisolone
1
Pentetic Acid
1
Oxycodone
1
Ondansetron
1
Music Therapy
1
Moxifloxacin
1
Morphine
1
Mitoxantrone
1
Minocycline
1
Methotrexate
1
Methadone
1
Mercaptopurine
1
Melphalan
1
Massage
1
Leucovorin
1
Injections
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Leukemia, Biphenotypic, Acute
×
Melphalan
×
Clear all
NCT00550992
2019-07-30
Interfant06
Dutch Childhood Oncology Group
Phase NA
Unknown
445 enrolled